| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activity of moxifloxacin and linezolid against Mycobacterium tuberculosis in combination with potentiator drugs verapamil, timcodar, colistin and SQ109
|
de Knegt, Gerjo J.
|
|
2017
|
49 |
3 |
p. 302-307
6 p.
|
artikel
|
| 2 |
Antimicrobial susceptibility and MIC distribution of 41 drugs against clinical isolates from China and reference strains of nontuberculous mycobacteria
|
Li, Guilian
|
|
2017
|
49 |
3 |
p. 364-374
11 p.
|
artikel
|
| 3 |
A propensity score-matched analysis of the impact of minimum inhibitory concentration on mortality in patients with Pseudomonas aeruginosa bacteraemia treated with piperacillin/tazobactam
|
Gentry, Chris A.
|
|
2017
|
49 |
3 |
p. 333-338
6 p.
|
artikel
|
| 4 |
Ciliates promote the transfer of a plasmid encoding bla NDM-5 from Escherichia coli, isolated from a hospital in Japan, to other human pathogens
|
Okubo, Torahiko
|
|
2017
|
49 |
3 |
p. 387-388
2 p.
|
artikel
|
| 5 |
Clinical and microbiological characteristics of bloodstream infections among patients with haematological malignancies with and without neutropenia at a medical centre in northern Taiwan, 2008–2013
|
Chen, Chien-Yuan
|
|
2017
|
49 |
3 |
p. 272-281
10 p.
|
artikel
|
| 6 |
Cold atmospheric pressure plasma elimination of clinically important single- and mixed-species biofilms
|
Modic, Martina
|
|
2017
|
49 |
3 |
p. 375-378
4 p.
|
artikel
|
| 7 |
Decreased tacrolimus plasma concentrations during HCV therapy: a drug–drug interaction or is there an alternative explanation?
|
Smolders, E.J.
|
|
2017
|
49 |
3 |
p. 379-382
4 p.
|
artikel
|
| 8 |
Effectiveness of purified methylene blue in an experimental model of Mycobacterium ulcerans infection
|
Tian, Roger B.D.
|
|
2017
|
49 |
3 |
p. 290-295
6 p.
|
artikel
|
| 9 |
Efficacy and safety of intermittent preventive treatment in schoolchildren with sulfadoxine/pyrimethamine (SP) and SP plus piperaquine in Democratic Republic of the Congo: a randomised controlled trial
|
Matangila, Junior R.
|
|
2017
|
49 |
3 |
p. 339-347
9 p.
|
artikel
|
| 10 |
Extended-spectrum β-lactamases, carbapenemases and the mcr-1 gene: is there a historical link?
|
Rhouma, Mohamed
|
|
2017
|
49 |
3 |
p. 269-271
3 p.
|
artikel
|
| 11 |
Intrathecal or intraventricular administration of colistin, vancomycin and amikacin for central nervous system infections in neurosurgical patients in an intensive care unit
|
Tsimogianni, Angeliki
|
|
2017
|
49 |
3 |
p. 389-390
2 p.
|
artikel
|
| 12 |
In vitro activity of clarithromycin in combination with other antimicrobial agents against Mycobacterium abscessus and Mycobacterium massiliense
|
Zhang, Zhijian
|
|
2017
|
49 |
3 |
p. 383-386
4 p.
|
artikel
|
| 13 |
In vitro and in silico analysis of the efficiency of tetrahydropyridines as drug efflux inhibitors in Escherichia coli
|
Silva Jr, Lande
|
|
2017
|
49 |
3 |
p. 308-314
7 p.
|
artikel
|
| 14 |
Is continuous infusion of imipenem always the best choice?
|
Suchánková, Hana
|
|
2017
|
49 |
3 |
p. 348-354
7 p.
|
artikel
|
| 15 |
Lipoteichoic acid synthesis inhibition in combination with antibiotics abrogates growth of multidrug-resistant Enterococcus faecium
|
Paganelli, Fernanda L.
|
|
2017
|
49 |
3 |
p. 355-363
9 p.
|
artikel
|
| 16 |
Population pharmacokinetics and dose optimisation of ritonavir-boosted atazanavir in Thai HIV-infected patients
|
Punyawudho, Baralee
|
|
2017
|
49 |
3 |
p. 327-332
6 p.
|
artikel
|
| 17 |
Safety and effectiveness of a 12-week course of sofosbuvir and simeprevir ± ribavirin in HCV-infected patients with or without HIV infection: a multicentre observational study
|
Bruno, Giuseppe
|
|
2017
|
49 |
3 |
p. 296-301
6 p.
|
artikel
|
| 18 |
Screening a repurposing library for potentiators of antibiotics against Staphylococcus aureus biofilms
|
Van den Driessche, Freija
|
|
2017
|
49 |
3 |
p. 315-320
6 p.
|
artikel
|
| 19 |
Synergy against extensively drug-resistant Acinetobacter baumannii in vitro by two old antibiotics: colistin and chloramphenicol
|
Wei, Wen-juan
|
|
2017
|
49 |
3 |
p. 321-326
6 p.
|
artikel
|
| 20 |
The Clostridium difficile quorum-sensing molecule alters the Staphylococcus aureus toxin expression profile
|
Essigmann, Heather T.
|
|
2017
|
49 |
3 |
p. 391-393
3 p.
|
artikel
|
| 21 |
The safe enterocin DD14 is a leaderless two-peptide bacteriocin with anti-Clostridium perfringens activity
|
Caly, Delphine L.
|
|
2017
|
49 |
3 |
p. 282-289
8 p.
|
artikel
|
| 22 |
Title Page & Editorial Board
|
|
|
2017
|
49 |
3 |
p. i-
1 p.
|
artikel
|
Tijdschrift beschrijving